Position in LH
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$629,440
-$34,650 QoQ
Shares Held
2,248
-9.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#537
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $8,380,568 across 10 Diagnostics & Research names. LH ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,677 | $3,848,940 | |
| 2 | DHR |
Danaher Corp /De/
|
5,333 | $1,015,829 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,565 | $823,878 | |
| 4 | LH |
Labcorp Holdings Inc.
This page
|
2,248 | $629,440 | |
| 5 | DGX |
Quest Diagnostics Inc
|
2,653 | $562,303 | |
| 6 | NTRA |
Natera, Inc.
|
1,673 | $454,135 | |
| 7 | ILMN |
Illumina, Inc.
|
1,716 | $301,724 | |
| 8 | WAT |
Waters Corp /De/
|
732 | $274,529 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629,440 | 2,248 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $664,090 | 2,489 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $686,658 | 2,737 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $705,880 | 2,459 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $622,673 | 2,372 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $550,197 | 2,364 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $552,431 | 2,409 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $561,828 | 2,514 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $489,645 | 2,406 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||